Literature DB >> 2115767

A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle.

J S Rothel1, S L Jones, L A Corner, J C Cox, P R Wood.   

Abstract

An in vitro cellular assay for bovine tuberculosis has recently been developed. This assay detects gamma-interferon released in response to specific antigen in a whole blood culture system. The bio-assay previously described for the detection of bovine gamma-interferon (IFN-gamma) has now been replaced with a sandwich enzyme immunoassay (EIA) which utilises two monoclonal antibodies to bovine IFN-gamma. The EIA detects less than 25pg/ml of recombinant bovine IFN-gamma and is specific for biologically active bovine IFN-gamma; and does not detect bovine alpha or beta interferon. IFN-gamma from sheep, goat and buffalo, but not from pig, deer or man, are also recognised by the EIA. The bovine IFN-gamma EIA when used in conjunction with the whole blood culture system has resulted in a simple, rapid and sensitive in vitro assay for specific cell mediated immune responsiveness to M. bovis infection in cattle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115767     DOI: 10.1111/j.1751-0813.1990.tb07730.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  59 in total

1.  Comparison between comparative tuberculin and gamma-interferon tests for the diagnosis of bovine tuberculosis in Ethiopia.

Authors:  G Ameni; H Miörner; F Roger; M Tibbo
Journal:  Trop Anim Health Prod       Date:  2000-10       Impact factor: 1.559

2.  Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70.

Authors:  Ingrid Olsen; Preben Boysen; Siri Kulberg; Jayne C Hope; Gregers Jungersen; Anne K Storset
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis.

Authors:  I Olsen; L J Reitan; G Holstad; H G Wiker
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  The effect of dexamethasone on some immunological parameters in cattle.

Authors:  B H Anderson; D L Watson; I G Colditz
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

Review 5.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

6.  Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.

Authors:  D N Wedlock; B Vesosky; M A Skinner; G W de Lisle; I M Orme; B M Buddle
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

7.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Antibody responses of cervids (Cervus elaphus) following experimental Mycobacterium bovis infection and the implications for immunodiagnosis.

Authors:  Noel P Harrington; Om P Surujballi; John F Prescott; J Robert Duncan; W Ray Waters; Konstantin Lyashchenko; Rena Greenwald
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

9.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Peripheral and gastrointestinal immune systems of healthy cattle raised outdoors at pasture or indoors on a concentrate-based ration.

Authors:  Alexandre Lejeune; Frank J Monahan; Aidan P Moloney; Bernadette Earley; Alistair D Black; Deirdre P Campion; Tanya Englishby; Petrina Reilly; John O'Doherty; Torres Sweeney
Journal:  BMC Vet Res       Date:  2010-03-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.